BCS Private Wealth Management’s GMO Ultra-Short Income ETF GMOC Stock Holding History

BCS Private Wealth Management’s Portfolio GMOC Stock Details GMOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251K	Hold	5,000	–	–	0.08%	167
2026 Q1	$251K	Buy	+5,000	New	+$251K	0.08%	164

Other funds holding GMOC

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BCS Private Wealth Management's GMOC Position: Q2 2026 in Review

BCS Private Wealth Management held its GMO Ultra-Short Income ETF (GMOC) position steady in Q2 2026 at 5,000 shares worth $251K. The position accounts for 0.08% of the portfolio, ranked #167.

BCS Private Wealth Management first reported a position in GMOC in Q1 2026 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold GMOC as of Q2 2026.

BCS Private Wealth Management held 5,000 shares of GMO Ultra-Short Income ETF worth $251K as of Q2 2026.
BCS Private Wealth Management left its GMO Ultra-Short Income ETF share count unchanged in Q2 2026.
GMO Ultra-Short Income ETF made up 0.08% of BCS Private Wealth Management's portfolio in Q2 2026, its #167 holding.
BCS Private Wealth Management first reported a position in GMO Ultra-Short Income ETF in Q1 2026 and has held it in 2 quarters since.
6 funds tracked by Wall St. Rank held GMO Ultra-Short Income ETF as of Q2 2026.

Based on BCS Private Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.